All-electric punching system market report: CAGR of 9.2% from 2025 to 2031

According to the all-electric punching system market report released by YH Research, this report provides the situation, definition, classification, application, and industrial chain structure of the all-electric punching system market. It also discusses development policies and plans, manufacturing processes, and cost structures, and analyzes the current development status and future market trends of the all-electric punching system market. It also analyzes the main production areas, main consumption areas, and main manufacturers of the all-electric punching system market from the perspectives of production and consumption.

According to authoritative data from YH Research, in 2024, the global all-electric punching system revenue scale will reach approximately 1.38 billion yuan. Looking ahead, by 2031, this revenue scale is expected to approach 2.56 billion yuan. During the period from 2025 to 2031, the compound annual growth rate (CAGR) is projected to reach 9.2%. These figures clearly illustrate the robust current state of the global all-electric perforation system market and also foreshadow its promising future development prospects.

Industrial Background Under Global Economic Governance Reforms
In 2025, the strategic restructuring of U.S. tariff measures is like a storm, profoundly reshaping global economic governance rules. This transformation has far-reaching and complex implications for the all-electric perforation system industry. The escalation of tariffs and international policy responses will influence corporate investment decisions through a series of intricate transmission mechanisms. Companies may reassess their production布局 and investment scales in different regions due to tariff adjustments. Meanwhile, regional trade networks may also be affected, with trade flows potentially shifting, thereby impacting the stability and efficiency of strategic material supply systems. For example, the supply of certain critical components may face delays or increased costs due to tariff changes, posing challenges to corporate production.

Technical Principles and Application Areas of All-Electric Perforation Systems
The fully electric perforation system is an advanced physical transfection technology device. Its core principle involves using electric pulses to create temporary microporous channels in cell membranes. These channels act as “passages” between cells and the external environment, enabling exogenous substances such as nucleic acids to enter the cell interior smoothly. By precisely controlling key parameters such as voltage, pulse width, and frequency, the system can achieve efficient transfection of various cell types, including bacteria, yeast, plants, and mammals.

In terms of application areas, the full-electric perforation system has demonstrated significant value. It is an indispensable tool in fields such as gene transduction, gene editing, vaccine development, and cell therapy. During gene transduction, it can accurately introduce target genes into cells, providing strong support for gene function research; in the field of gene editing, it offers an efficient cell delivery method for the application of gene editing technologies such as CRISPR; in vaccine development, it facilitates the rapid construction of vaccine vectors, accelerating the vaccine R&D process; in cell therapy, it enables efficient modification of immune cells, laying the foundation for the development of cell therapy technologies such as CAR-T.

Market Segmentation Landscape and Competitive Dynamics
The fully electric perforation system occupies a key position as a physical transfection platform in current cell manipulation and gene delivery experiments, and has been widely adopted in life science research and the biopharmaceutical industry.

Research Market
In the research sector, diverse cell compatibility, high transfection efficiency, and reproducibility are core requirements. Companies such as Bio-Rad, BTX, and Nepa Gene have keenly identified this market demand and provide small-to-medium-sized systems suitable for a wide range of research scenarios. These systems feature flexible operation and relatively low costs, meeting the needs of researchers under various experimental conditions. For example, a research team conducting plant cell gene editing research selected Nepa Gene's small-to-medium-sized fully electric perforation system. Leveraging its high transfection efficiency and excellent cell compatibility, the team successfully achieved the editing of the target gene, laying the foundation for subsequent research.

Biopharmaceutical and Gene Therapy Sector
In the biopharmaceutical and gene therapy sector, there is a growing demand for high-throughput, scalable production. Companies such as MaxCyte, Lonza, and Celetrix have seized this market opportunity by offering modular systems tailored for GMP production. These systems support cutting-edge applications such as CAR-T and mRNA delivery, meeting the large-scale production needs of biopharmaceutical companies. For instance, a biopharmaceutical company adopted MaxCyte's modular full electroporation system to achieve efficient preparation of CAR-T cells, significantly enhancing production efficiency and product quality.

Closed-loop solution providers
Some companies, such as Thermo Fisher and STEMCELL, have established closed-loop solutions by integrating consumables with electroporation systems. These solutions enhance experimental consistency and reduce variable interference during the experimental process. For example, after using Thermo Fisher's closed-loop solution, a laboratory saw a significant improvement in the reproducibility of experimental results, providing strong support for the smooth conduct of research work.

The overall market presents a trend of “research support and industry leadership” advancing in tandem, with a clear competitive landscape among global leading manufacturers. Product technical barriers and bioprocess compatibility have become the focal points of differentiated competition. Companies must continuously enhance their technical capabilities and optimize product compatibility with bioprocesses to stand out in the intense market competition.

Key regions and segments in the global market
This article focuses on the all-electric perforation system market in multiple countries and regions, including the North American market (United States, Canada, and Mexico), the European market (Germany, France, United Kingdom, Russia, Italy, and other European countries), the Asia-Pacific market (China, Japan, South Korea, India, Southeast Asia, and Australia, etc.), the South American market (Brazil, etc.), and the Middle East and Africa region. These regions vary in terms of economic development levels, research and development capabilities, and the degree of development of the biopharmaceutical industry, resulting in differing demands for fully electric perforation systems.

By product type, the market includes eukaryotic cells, prokaryotic cells, and other types. Different cell types have varying parameter requirements for fully automated electroporation systems, necessitating targeted product development and production based on market demand.

By application, the market covers life science research, biopharmaceuticals and gene therapy, agriculture and plant science, and other fields. As biotechnology continues to advance, the application prospects for fully automated electroporation systems across all these fields will become increasingly broad.

Global Major Manufacturers
Globally, the major manufacturers of full-electric perforation systems include Bio-Rad, Thermo Fisher, Nepa Gene, BTX, Lonza, BEX, STEMCELL, Labtron, MaxCyte, Celetrix Biotechnologies, Biontex, and others. These manufacturers each have their own advantages in terms of technological R&D, product quality, and market share, collectively driving the development of the global full-electric perforation system market.